Technica Labs & Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 9.70 M
as on 17-11-2024
- Company Age 26 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.34 Cr
as on 17-11-2024
- Satisfied Charges ₹ 11.25 Cr
as on 17-11-2024
- Revenue -5.34%
(FY 2023)
- Profit -1.02%
(FY 2023)
- Ebitda -4.80%
(FY 2023)
- Net Worth 0.84%
(FY 2023)
- Total Assets -5.86%
(FY 2023)
About Technica Labs & Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.70 M.
The company currently has active open charges totaling ₹5.34 Cr. The company has closed loans amounting to ₹11.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajneesh Goel and Seema Goel serve as directors at the Company.
- CIN/LLPIN
U24117UR1998PTC023256
- Company No.
023256
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Technica Labs & Pharma Private Limited offer?
Technica Labs & Pharma Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Digestive System Drugs & Medicines, Antacid Drugs, Anti Infective Drugs & Medicines, Antibacterial Drugs.
Who are the key members and board of directors at Technica Labs & Pharma?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajneesh Goel | Director | 20-Mar-1998 | Current |
Seema Goel | Director | 20-Mar-1998 | Current |
Financial Performance of Technica Labs & Pharma.
Technica Labs & Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.34% decrease. The company also saw a slight decrease in profitability, with a 1.02% decrease in profit. The company's net worth moved up by a moderate rise of 0.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Technica Labs & Pharma?
In 2023, Technica Labs & Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Avenir Life Science Private LimitedActive 19 years 3 months
Rajneesh Goel and Seema Goel are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 14 Dec 2021 | ₹3.50 M | Open |
Others Creation Date: 18 Jun 2021 | ₹2.85 M | Open |
Others Creation Date: 27 Nov 2019 | ₹1.37 Cr | Open |
How Many Employees Work at Technica Labs & Pharma?
Technica Labs & Pharma has a workforce of 3 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Technica Labs & Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Technica Labs & Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.